HSA
EGRX

Hussman Strategic Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Hussman Strategic Advisors’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,000
Closed -$1.01M – 279
2018
Q4 		$1.01M Hold
25,000
– – 0.24% 159
2018
Q3 		$1.73M Buy
+25,000
New +$1.73M 0.5% 90